RxDoctor Payments Data

Shauna Wojciechowski, NP

Family · Fairfield, OHNPI 1982027033

Payments from drug & device makers

$402in general payments, 2019–2025

Across 21 payments — averaging $19.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Exact Sciences$75
  • Imperative Care, Inc$51
  • AbbVie$50
  • Abbott$39
  • Pfizer$36
  • Novo Nordisk$32
  • plus $118 from 6 others

What the payments were for

  • Food & beverage$402100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$402 in reported general payments places this provider in the 50th percentile of 6,812 family providers in Ohio.

See all family providers in Ohio

Medicare billing

Part B allowed, 2024
$38,611
Medicare patients
215
Services billed
604

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide31$29,620
MounjaroTirzepatide20$22,958
TrulicityDulaglutide24$21,314
EliquisApixaban14$12,805
LinzessLinaclotide11$11,281
Toujeo SolostarInsulin Glargine,hum.Rec.Anlog11$6,110
Lantus SolostarInsulin Glargine,hum.Rec.Anlog27$4,488
Humalog Kwikpen U-100Insulin Lispro11$2,862
Albuterol Sulfate HfaAlbuterol Sulfate79$2,644
Atorvastatin Calcium249$2,641
Duloxetine Hcl70$1,636
MyrbetriqMirabegron14$1,587
Lisinopril189$1,460
Gabapentin100$1,404
Potassium Chloride35$1,099

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$32$29,62031 claims
PfizerEliquis$36$12,80514 claims
AbbVieLinzess, Synthroid$50$12,13243 claims
Astellas Pharma US IncMyrbetriq$19$1,58714 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 6,812 family providers in Ohio.

Other family in Fairfield

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →